Kyverna Therapeutics Inc (KYTX) PT Lowered to $33 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts KYTX Hot Sheet
Price: $6.39 --0%
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 30
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 30
Join SI Premium – FREE
JPMorgan analyst Brian Cheng lowered the price target on Kyverna Therapeutics Inc (NASDAQ: KYTX) to $33.00 (from $39.00) while maintaining a Overweight rating.
You May Also Be Interested In
- LVMH Moet Hennessy Louis Vuitton SE (MC:FP) (LVMUY) PT Lowered to EUR520 at BofA Securities
- Rentokil Initial Plc. (RTO:LN) (RTO) PT Lowered to GBP4.15 at BofA Securities
- Avenue Supermarts (DMART:IN) PT Lowered to INR4,500 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
